SCHEMBL5340342

SCHEMBL5340342

COC(=O)c1cccc(Oc2cccc(F)c2F)c1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.42
SLC6A4 P31645 1/20 0.42
TSHR P16473 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CES2 O00748 1/20 0.41
BCHE P06276 1/20 0.41
CES1 P23141 1/20 0.41
KMT2A Q03164 4/20 0.40
HSD17B10 Q99714 3/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 4/20 0.40
LMNA P02545 1/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31454562 0.81 TSHR (0.48) SLC6A3SLC6A4TSHRCYP1A2CYP2D6
SCHEMBL1673040 0.81 TSHR (0.48) SLC6A3SLC6A4TSHRCYP1A2CYP2D6
SCHEMBL1027499 0.78 HSD17B10 (0.57) SLC6A3TSHRKMT2AHSD17B10GAA
SCHEMBL1340852 0.78 CES2 (0.61) SLC6A3SLC6A4TSHRCYP1A2CYP2D6
SCHEMBL5365431 0.77 ABL1 (0.44) SLC6A3SLC6A4SMN1; SMN2KMT2AALDH1A1
SCHEMBL2842204 0.76 TSHR (0.57) TSHRCYP1A2CYP2D6CYP2C19KMT2A
SCHEMBL28829627 0.75 SLC6A3 (0.57) SLC6A3SLC6A4TSHRCYP1A2CYP2D6
SCHEMBL31388963 0.75 NR1I2 (0.46) SLC6A3SLC6A4TSHRCYP1A2CYP2D6
SCHEMBL1957490 0.72 HTT (0.57) TSHRCYP1A2CES2BCHECES1
SCHEMBL13824070 0.72 SLC6A3 (0.53) SLC6A3SLC6A4TSHRNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784390-A2 SUBSTITUTED BENZOFUSED HETEROCYCLES Amgen Inc. (US) 2007-05-16 EP disclosed
WO-2006020959-A2 SUBSTITUTED BENZOFUSED HETEROCYCLES AMGEN INC. (US) 2006-02-23 WO disclosed